Glen Kacher’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-511,850
Closed -$63.6M 60
2021
Q2
$63.6M Buy
+511,850
New +$68.8M 2.76% 11
2021
Q1
Sell
-162,900
Closed -$21M 52
2020
Q4
$21M Buy
+162,900
New +$18.7M 0.63% 38

Other funds holding GH

Glen Kacher's GH Position: Q3 2021 in Review

Glen Kacher sold out of Guardant Health (GH) in Q3 2021, closing a stake of 511,850 shares — an estimated $63.6M sold.

Glen Kacher first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $63.6M in Q2 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Glen Kacher reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Glen Kacher sold 511,850 Guardant Health shares in Q3 2021, an estimated $63.6M.
  • Glen Kacher first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
  • Glen Kacher's Guardant Health position peaked at $63.6M in Q2 2021.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Light Street Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.